The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck.

Medicina (Kaunas) · 2023 · PMC10745089 · PMID 38138214

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Importantly, the tyrosine kinase inhibitor (TKI) axitinib showed a trend toward superior progression-free survival (PFS) in ACC patients with MYB/NFIB rearrangements [ 31 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.